Michael is a partner in the firm’s Corporate and M&A Group.

Michael focuses on advising financial investors and public and private companies on all types of domestic and cross-border M&A, including public and private acquisitions, carve-outs and spin-offs, public to privates, private investments and joint-venture structures. Michael also advises clients on shareholder activism, takeover defense, restructurings, corporate governance, executive incentivisation and securities law matters.

Relevant Experience

Private Capital Deals

• Starwood on its investment in Echelon Data Centres
• Chanelle Pharma on its sale to Exponent
• Pontegadea on its Irish real estate investments
• Clune Tech Group on the sale of Immedis and $1 billion Transfermate funding
• AssuredPartners on the acquisition of O’Callaghan Insurance, O’Donovan Insurance, Fitzgerald Insurance and Sayers Insurance
• HG Capital on the establishment of the Bright Software Group and acquisitions of Brightpay, Thesaurus, Surf, Accountancy Manager
• KKR – Biosynth Carbosynth on its acquisition of Aalto Bio Reagents, Hyperion Materials & Technologies on its acquisition of NanoDiamond Products and the establishment of and investment in the Activate Capital Irish lending platform
• Pritzker Private Capital – ProAmpac acquisitions of Tool and Plastic, Irish Flexible Packaging and Fispak
• HIG Capital on its Irish real estate joint venture structures
• Leeds Private Equity on its acquisition of Interactive Services

Public and P2P Deals

• Jazz Pharmaceuticals on its $7 billion acquisition of GW Pharmaceuticals
• Praxair Inc. on its $70 billion merger with Linde Ag
• Epiris on its acquisition of IFG Group plc